Disruption of TNK2 leads to reduced cell growth, halted cell cycle progression, increased apoptosis, and heightened susceptibility to radiation [45–48], suggesting that TNK2 has promise as a potential target for treating malignant tumors. The gene discussed is TNK2; the disease is cancer.